Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


June 03, 2015 5:49 AM ET

Pharmaceuticals

Company Overview of Replidyne, Inc.

Executive Profile

Christopher D. Earl Ph.D.

Former Director and Member of Audit Committee, Replidyne, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 4 different industries.

See Board Relationships
59--

Background

Dr. Christopher D. Earl, also known as Chris, Ph.D., serves as the President of Innotrove, LLC. Dr. Earl is an entrepreneur, investor and nonprofit leader with broad experience in science, venture capital and the management of biotechnology companies and nonprofit organizations. Through Innotrove LLC, Dr. Earl serves as Senior Advisor to Merck & Co.'s two corporate venture capital funds. He served as an Advisor at Aisling Capital LLC. Dr. Earl joined the firm in 1997 ...

Corporate Headquarters

1450 Infinite Drive
Louisville, Colorado 80027

United States

Phone: 303-996-5500
Fax: 303-996-5599

Board Members Memberships

Former Director
Director
Director
Director
Former Director
2004-2008
Former Director and Member of Audit Committee
2009-N/A
Former Outside Director

Education

PhD
Harvard University
BA
The University of Pennsylvania

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Replidyne, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.